NR3C2 and myeloid sarcoma: This study aims to explore the molecular mechanisms underpinning microglial involvement in MS, utilising multiple techniques such as RNA sequencing, single‐cell sequencing, and MR to better understand their roles and identify potential therapeutic targets.